The present investigation is one of the very few studies conducted among Brazilian patients with GC and GEJC, adding valuable evidence on the prevalence of three critical biomarkers: CPS PD-L1, MSI, and HER-2. This evidence concerns the gene ERBB2 and gastric cancer.